Key Takeaways
- ARK Invest purchased 39,691 shares of Tesla valued at $14.3M spread across three ETFs on April 6, 2026
- Tesla shares declined more than 2% to $352.82 following a disappointing first-quarter delivery announcement
- ARK divested 25,240 Teradyne shares valued at $7.8M, marking continued reduction in the position
- Wedbush’s Dan Ives maintained his Buy recommendation with a $600 target price for Tesla
- JPMorgan’s Ryan Brinkman sustained his Sell rating, setting a $145 price objective
Cathie Wood’s investment firm ARK Invest executed several notable portfolio adjustments on Monday, April 6, 2026, accumulating shares of Tesla while trimming its stake in semiconductor testing equipment manufacturer Teradyne.
Tesla’s stock price experienced a decline exceeding 2% during the trading session, finishing at $352.82. This downturn followed the electric vehicle manufacturer’s release of first-quarter delivery figures that fell short of market expectations.
Wood’s firm acquired 39,691 shares of Tesla distributed among three exchange-traded funds — ARK Innovation, ARK Autonomous Technology & Robotics, and ARK Space Exploration & Innovation. The combined transaction totaled approximately $14.3 million.
This purchase represents part of a broader strategy. ARK has been consistently expanding its Tesla holdings, capitalizing on recent share price declines as an entry point.
Meanwhile, ARK disposed of 25,240 shares of Teradyne valued at $7.8 million through its ARKK and ARKQ portfolios. This follows previous sales executed on March 30 and March 31, indicating a strategic withdrawal from the semiconductor testing equipment company.
Analyst Community Remains Polarized on Tesla
Not all market observers share Wood’s optimistic outlook on Tesla at this juncture.
Wedbush Securities analyst Dan Ives, who carries a five-star rating, reaffirmed his Buy recommendation along with a $600 price objective following the delivery announcement. While acknowledging the underwhelming results, he noted that subdued demand had already been anticipated by much of the analyst community.
Conversely, JPMorgan analyst Ryan Brinkman maintained his contrarian stance. He preserved his Sell rating alongside a $145 price target, characterizing Tesla’s performance as having “collapsed” across critical operational indicators.
The substantial disparity between these two forecasts — $145 compared to $600 — illustrates the significant disagreement among Wall Street professionals regarding the stock’s trajectory.
Based on assessments from 32 analysts surveyed during the past three months, Tesla carries a consensus Hold rating. The breakdown includes 13 Buy ratings, 11 Hold ratings, and 8 Sell recommendations.
The mean price objective stands at $393.97, representing approximately 11.66% potential appreciation from Monday’s closing price.
Additional ARK Portfolio Adjustments on April 6
ARK Invest also liquidated 29,773 shares of BWX Technologies for $6.4 million and divested 8,484 shares of Cameco worth $955,043.
The investment firm additionally sold 92,758 shares of Strata Critical Medical, generating approximately $384,945. This selling activity has persisted since the previous week.
On the acquisition front, ARK purchased 4,394 shares of Kodiak AI via its ARKQ ETF, totaling $32,603. The fund has been steadily building its Kodiak AI position since March 30.
Current Market Position
As of April 6, Tesla concluded trading at $352.82, with the consensus analyst price target of $393.97 indicating modest but favorable upside potential from current trading levels.
